Tianqi Li

Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway

Lisha Du, Zikang Xing, Bangbao Tao et al. · Signal Transduction and Targeted Therapy · 2020 · 147 citations · Full text

Medicine, Molecular Biology, Oncology +12

IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer

Heng Liang, Tianqi Li, Xin Fang et al. · Cancer Letters · 2021 · 67 citations

Medicine, Cancer Biology, Oncology +7

Integrated analysis of long noncoding <scp>RNA</scp> associated‐competing endogenous <scp>RNA</scp> as prognostic biomarkers in clear cell renal carcinoma

Hang Yin, Xiaoyuan Wang, Xue Zhang et al. · Cancer Science · 2018 · 59 citations · Full text

Medicine, Bioinformatics, Oncology +17

Inflammation, negative affect, and amyloid burden in Alzheimer’s disease: Insights from the kynurenine pathway

Auriel A. Willette, Colleen Pappas, Nathan Hoth et al. · Brain Behavior and Immunity · 2021 · 57 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells

Miao Ding, Biaoyang Lin, Tao Li et al. · Oncotarget · 2015 · 55 citations · Full text

Medicine, Molecular Biology, Oncology +17